Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04268316 · ClinicalTrials.gov registry record · NA
Virtual Reality Behavioral Activation: An Intervention for Major Depressive Disorder
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT04268316: Completed NA study, sponsored by Stanford University.
NCT04268316 is a NA study that has completed, run by Stanford University. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04268316, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The primary purpose of this study is to test the safety and feasibility of virtual reality (VR) technology in the use of behavioral activation (BA) as a treatment for major depressive disorder (MDD). The secondary purpose of this study is to examine whether any evidence of clinical efficacy exists for VR delivered BA.
Interventions
- DEVICE Virtual Reality Behavioral Activation
- BEHAVIORAL Behavioral Activation in real-life
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2020-05-18 |
| Est. Completion | 2021-01-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04268316
The ClinicalTrials.gov registry entry for NCT04268316 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Virtual Reality Behavioral Activation is the first listed.
NCT04268316 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04268316 about?
NCT04268316 is a clinical study titled "Virtual Reality Behavioral Activation: An Intervention for Major Depressive Disorder". The primary purpose of this study is to test the safety and feasibility of virtual reality (VR) technology in the use of behavioral activation (BA) as a treatment for major depressive disorder (MDD). The secondary purpose of this study is to examine whether any evidence of clinical efficacy exists f...
What is the current status of trial NCT04268316?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2020-05-18. Estimated completion is 2021-01-15.
What interventions are being tested in trial NCT04268316?
The interventions under investigation include: Virtual Reality Behavioral Activation (DEVICE), Behavioral Activation in real-life (BEHAVIORAL).
Who is sponsoring clinical trial NCT04268316?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.